American Century Companies Inc. Boosts Stock Holdings in OraSure Technologies, Inc. $OSUR

Key Points

• American Century Companies Inc. increased its stake in OraSure Technologies, Inc. by 6.8%, holding over 2.5 million shares worth approximately $8.4 million as of the latest filing.
• Various other institutional investors, including Private Management Group Inc. and D. E. Shaw & Co. Inc., have also significantly invested in OraSure Technologies, indicating strong institutional interest in the company.
• OraSure Technologies' stock price has fluctuated between a 12-month low of $2.36 and a high of $4.61, with a current trading price of $3.48 and an average analyst rating of "Hold" with a price target of $3.00.

American Century Companies Inc. boosted its stake in shares of OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,505,124 shares of the medical instruments supplier's stock after buying an additional 159,287 shares during the quarter. American Century Companies Inc. owned 3.23% of OraSure Technologies worth $8,442,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Private Management Group Inc. acquired a new position in OraSure Technologies during the first quarter worth about $14,886,000. Millennium Management LLC grew its position in shares of OraSure Technologies by 16.7% in the fourth quarter. Millennium Management LLC now owns 2,158,450 shares of the medical instruments supplier's stock valued at $7,792,000 after purchasing an additional 308,420 shares during the last quarter. Systematic Financial Management LP grew its position in shares of OraSure Technologies by 33.7% in the fourth quarter. Systematic Financial Management LP now owns 1,673,609 shares of the medical instruments supplier's stock valued at $6,042,000 after purchasing an additional 421,497 shares during the last quarter. D. E. Shaw & Co. Inc. grew its position in shares of OraSure Technologies by 180.5% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,517,541 shares of the medical instruments supplier's stock valued at $5,478,000 after purchasing an additional 976,475 shares during the last quarter. Finally, Bridgeway Capital Management LLC grew its position in shares of OraSure Technologies by 13.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 1,230,106 shares of the medical instruments supplier's stock valued at $4,441,000 after purchasing an additional 143,487 shares during the last quarter. 93.50% of the stock is currently owned by institutional investors and hedge funds.

OraSure Technologies Stock Up 0.6%

Shares of OSUR traded up $0.02 on Friday, hitting $3.31. 747,291 shares of the stock traded hands, compared to its average volume of 632,416. The firm has a market capitalization of $242.09 million, a P/E ratio of -4.94 and a beta of 0.27. The stock's 50 day moving average is $3.07 and its two-hundred day moving average is $3.10. OraSure Technologies, Inc. has a 1 year low of $2.36 and a 1 year high of $4.61.

Wall Street Analyst Weigh In

Several research firms have recently commented on OSUR. Wall Street Zen upgraded shares of OraSure Technologies from a "sell" rating to a "hold" rating in a research report on Saturday, May 17th. Evercore ISI reiterated an "in-line" rating and issued a $3.00 price target on shares of OraSure Technologies in a research report on Monday, May 19th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of "Hold" and an average price target of $3.00.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.